[1] AMARENCO P，LAVALLéE P C，MONTEIROTAVARES L，et al. Five-Year Risk of Stroke afterTIA or Minor Ischemic Stroke[J/OL]. N Engl J Med，2018 [Epub ahead of print]. https：//doi.org/10.1056/NEJMoa1802712.[2] THOMALLA G，SIMONSEN C Z，BOUTITIEF，et al. MRI-Guided Thrombolysis for Stroke withUnknown Time of Onset[J/OL]. N Engl J Med，2018[Epub ahead of print]. https：//doi.org/10.1056/NEJMoa1804355.[3] HART R G，SHARMA M，MUNDL H，et al.Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source[J/OL]. N Engl J Med，2018 [Epub ahead of print]. https：//doi.org/10.1056/NEJMoa1802686.[4] JOHNSTON S C，EASTON J D，FARRANT M，et al. Clopidogrel and Aspirin in Acute IschemicStroke and High-Risk TIA[J/OL]. N Engl J Med，2018 [Epub ahead of print]. https：//doi.org/10.1056/NEJMoa1800410.[5] WANG Y，WANG Y，ZHAO X，et al. Clopidogrelwith aspirin in acute minor stroke or transientischemic attack[J]. N Engl J Med，2013，369（1）：11-19.[6] PAN Y，JING J，CHEN W，et al. Risks and benefitsof clopidogrel-aspirin in minor stroke or TIA：Timecourse analysis of CHANCE[J]. Neurology，2017，88（20）：1906-1911.[7] WANG Y，ZHAO X，LIN J，et al. AssociationBetween CYP2C19 Loss-of-Function Allele Statusand Efficacy of Clopidogrel for Risk ReductionAmong Patients With Minor Stroke or TransientIschemic Attack[J]. JAMA，2016，316（1）：70-78.
